Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,296 total articles
Monster Beverage is a cash-rich category leader priced at a steep multiple. We like a disciplined long here: entry at $77.24, stop at $70.00, target $95.00 over a 180-trading-day horizon. The trade banks on continued category growth and strong free cash flow while respecting a premium P/E and concentrated share structure.
Intuitive Machines is benefiting from NASA momentum, a $180.4M lunar cargo award, and a rapidly improving order pipeline. The stock is trading near recent highs but still offers asymmetric upside if the company converts contracts into cadence and revenue. This trade idea lays out an entry at $27.70, a $38.00 target and a $22.00 stop for a long-term…
IPG Photonics (IPGP) is trading at a high multiple but is showing above-average revenue momentum driven by EV battery, medical, and defense demand. The company has a strong balance sheet, product catalysts coming in 2026, and recent beats that justify a targeted long trade over the next 180 trading days. Risk is material — valuation and execution a…
Moog (MOG.A) is a niche leader in precision motion and fluid controls for aerospace, defense and industrial customers. With roughly $10.1B market cap, $215M of trailing free cash flow and a conservative balance sheet, the stock looks set to grind higher as defense spend and space/aircraft modernization drive backlog and margins. This trade idea giv…
AXIA Energia is a large Brazilian generator and transmitter trading near a 52-week high with a 6.3% yield, constructive technical momentum and a valuation that prices growth into utility earnings. This trade idea outlines a mid-term long with specific entry, stop and target levels and explains the fundamental case, valuation framing, catalysts and …
Nektar shares surged after clinical proof-of-concept and clear late-stage execution on REZPEG. The market is pricing a premium, but the combination of limited float, improving technicals, and near-term development catalysts make this a strong buy for a disciplined long with a 180-trading-day horizon. Key risks include ongoing securities litigation,…
We upgrade Eli Lilly (LLY) to Buy. The company sits on an expanding GLP-1 franchise after FDA approval of its oral obesity pill Foundayo and still has room to re-accelerate toward a $1 trillion valuation. Fundamentals - including $8.97B in free cash flow, a trailing EPS of $23.10, and a market cap near $870B - support a mid-term price target of $1,…
NerdWallet is showing durable profitability and cash generation even as organic search faces headwinds. The business trades at a modest multiple to free cash flow and EV, with a clean balance sheet and rising analyst price targets. This trade idea proposes a long entry at $11.00 with a $16.00 target on a 180-trading-day horizon and a $9.50 stop.
DuPont is trading at a conservative valuation relative to its asset base and cash generation. Balance-sheet strength, improving technicals, and durable end-market growth in aramid fibers, packaging barrier coatings and water treatment support upside. This trade idea outlines an entry at current levels, strict risk control and multi-horizon targets …
Douglas Dynamics (PLOW) combines a near-duopoly position in work-truck plow attachments, a meaningful earnings rebound in 2025, and a recent strategic acquisition. The stock trades at $46.16 with a reasonable valuation versus free cash flow and an attractive dividend. We outline a mid-term trade idea targeting $55 with a $42 stop, driven by winter-…
AST SpaceMobile has been punished on headline risk and execution doubts, but the core value proposition - direct-to-phone LEO connectivity without special handsets - remains unique. This trade targets a mean-reversion and milestone-driven re-rating if commercial partnerships and regulatory clearances progress. Entry, stop and targets reflect a high…
Hitachi's recent deals in mobility and intelligent transportation plus positive macro flows into Japanese industrials provide a reasoned entry for a swing trade. The company's diversified exposure to digital services, energy infrastructure and rail systems, paired with bullish technical momentum, supports a buy at current levels with a target near …
Honeywell enters Q1 reporting season with active portfolio simplification that should de-risk the business mix, but the shares already reflect much of that progress. We outline a tactical neutral/swing trade that buys a measured dip and protects capital while leaving room to re-evaluate once Q1 results and the PSS sale clarity arrive.
Rigetti (RGTI) looks like a high-conviction swing trade as quantum-sector optimism from Nvidia's Ising announcement and fresh S&P commentary drives flows into the space. The company is priced for perfection at a $6.28B market cap, but short-term technicals, rising volume and a crowded short make a mid-term long with strict risk controls attractive.
Credo Technology (CRDO) sits squarely in the data-center connectivity bottleneck that is limiting GPU scaleouts. Recent results and the DustPhotonics acquisition accelerate Credo's move from electrical to optical solutions. Given 200%+ revenue growth, healthy gross margins and a clear roadmap to >$500M optical revenue in FY2027, this is a convictio…
Kura Oncology's recent combo signal in renal cell carcinoma and its commercial progress with ziftomenib create a favorable setup. At a market cap under $900M and with cash on the balance sheet, KURA looks positioned for a near- to mid-term re-rating if follow-up data and commercial uptake continue. This trade idea lays out an entry at $9.65, a $14.…
Academy Sports and Outdoors trades at roughly a 10x P/E and a 6.2x EV/EBITDA multiple, while returning cash to shareholders and accelerating store and e-commerce growth. We lay out a long trade that targets a re-rating into the mid-$60s to $70s as the company benefits from new store openings, continued e-commerce traction, and seasonal/sports deman…
Core & Main (CNM) is a specialist distributor for water, wastewater and related infrastructure whose fundamentals—$604M free cash flow, return on equity ~22%, and EV/EBITDA ~12.6—support a long-term core position. We outline an actionable trade: enter at $50.00, stop at $46.00, target $62.00 over a long-term (180 trading days) horizon.
Evolv Technologies is showing tangible commercial progress: accelerating revenue, positive adjusted EBITDA in recent quarters, institutional buying, and a falling short interest backdrop. The stock is still unprofitable and carries headline legal risk, but for disciplined traders the risk/reward over the next 45 trading days looks favorable around …
ICICI Bank (IBN) has the technical and valuation setup for a confident swing trade after a recent re-rating. At a market cap of roughly $105.2B, P/E of 16.8 and PB of 2.65, the stock is showing bullish momentum (RSI 64, positive MACD) and tighter short-interest dynamics. This trade targets a move toward prior 52-week highs while keeping a disciplin…
PayPal trades below $51 with an earnings multiple under 9 and free cash flow north of $5.5B. Recent execution stumbles and a management change created an entry point. This trade targets a rebound as revenue growth stabilizes and operating leverage reappears; plan is a mid-term swing for 45 trading days with a defined entry, stop and target.
COMPASS Pathways (CMPS) is a clinical-stage psychedelic biotech that just moved from speculative to actionable following positive late-stage data and a heavy-volume breakout. The market now prices a near-$900M market cap into a pathway toward commercial psilocybin therapy; this trade idea targets the next leg up while explicitly protecting for regu…
ICICI Bank's latest quarter showed the core operating engine holding up despite macro noise. The stock has pulled back sharply on macro-led selling; we see a tactical long entry to capture a mid-term recovery backed by improving franchise metrics and benign asset-quality trends.
Compass shares are trading below recent highs after a transformational merger and a convertible note raise. With a market cap near $6.0B, positive free cash flow, and a P/S below 1.0, I'm constructive. This is a tactical, mid-term long: entry at $8.00, target $12.00, stop $6.50, horizon ~45 trading days.
Conagra yields near 9.4% at $14.90, but weak sales, negative EPS, thin liquidity and meaningful debt argue for a dividend cut to fund debt paydown. Expect near-term downside if the market starts to price in a lower payout or a disciplined deleveraging plan. Trade idea: short CAG at $14.90, stop $16.50, target $10.00 over a mid-term (45 trading days…
